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Abstract
Background and Aims: The Roma (Gypsies) are a transnational minority, founder population characterized by
unique genetic background modeled by culturally determined endogamy. The present study explores whether the
widely found cardiovascular diseases (CVD) risk effects of ACE I/D, APOE (ε2, ε3, ε4), eNOS-VNTR and LEP G2548A
polymorphisms can be replicated in this specific population.
Methods and Results: The community-based study was carried on 208 adult Bayash Roma living in rural
settlements of eastern and northern Croatia. Risk effect of four CVD candidate polymorphisms are related to the
most prominent classical CVD risk phenotypes: obesity indicators (body mass index and waist circumference),
hypertension and hyperlipidemia (triglycerides, HDL and LDL cholesterol). For all of them the standard risk cut-offs
were applied. The extent to which the phenotypic status is related to genotype was assessed by logistic regression
analysis. The strongest associations were found for ε2 allele of the APOE as a predictor of waist circumference (OR
3.301; 95%CI 1.254-8.688; p = 0.016) as well as for BMI (OR 3.547; 95%CI 1.471-8.557; p = 0.005). It is notable that ε3
allele of APOE gene turned out to be a protective genetic factor determining low lipid levels.
Conclusion: The strength of the relation and the similarity of the results obtained for both tested indicators of
obesity provide firm evidence that APOE plays an important role in obesity development in the Roma population.
Findings
The Roma are a transnational minority population of
Indian origin fragmented in numerous, often endoga-
mous, smaller groups dispersed throughout Europe, in
which the influence of genetic drift is highly emphasized
[1-3]. The Roma are also characterized by numerous
cultural (life-style) specificities that could contribute to
their increased risk for cardiovascular diseases (CVD).
T h ep u r p o s eo ft h ep r e s e n ts t u d yi s ,t h e r e f o r e ,t o
examine whether the unique Bayash Roma genetic
background exposed some new relations amongst well-
known genetic and non-genetic CVD risk factors. The
association between classical CVD risk phenotypes
(hypertension, obesity and lipid status) and the four
widely investigated CVD candidate gene polymorphisms
is tested: ACE I/D, APOE (ε2, ε3, ε4), eNOS-VNTR
(4,5) and LEP G2548A [4-7].
A total of 230 adult members of the Roma population
(78 men and 152 women) aged 20-84 yrs (50.1 ± 14.1)
living in rural settlements in Eastern and Northern
Croatia were included in the study. All examinees
voluntarily participated and before signing the informed
consent were informed about the goals, methods and
expectations of the study. The study protocol was
approved by the local Ethical Committee.
Small samples of peripheral blood (7.5 ml) were col-
lected for genetic and core biochemical analyses (fasting
glucose, triglycerides, HDL, LDL and total cholesterol).
DNA was extracted from blood samples using the salt-
ing out method. Alu I,D (ACE), G-2548A (LEP), VNTR-
4,5 (eNOS), and ε2, ε3, ε4 (APOE) polymorphisms were
genotyped by applying respective methods [8-10].
Short anthropometry was undertaken [11] and
the obesity status was defined using body mass index
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2) and waist circumfer-
ence [12]. Blood pressure measurements were per-
formed in the sitting position, after 10-15 minutes rest,
through the use of a mercury sphygmomanometer by an
experienced and certified examiner.
Allele frequencies were calculated from genotype fre-
quencies. Deviation from Hardy-Weinberg equilibrium
was assessed by exact test. All data (genetic, anthropo-
metric, biochemical) were analyzed univariately using
standard statistical methods for quantitative and qualita-
tive variables (data not shown). For each CVD risk pheno-
type the genotypic odds ratios of selected polymorphisms
were estimated using logistic regression analysis
including combined effects of sex, age, and other biological
covariates. For all studied polymorphisms each homozy-
gote genotype was tested against the other two genotypes.
All analyses were performed by SPSS 10.0 statistical
package.
The prevalence of CVD risk phenotypes in this sample
together with employed standard cut-off values (code 2,
for logistic regression) is presented on Table 1. The data
demonstrate that the Roma have a serious burden for
CVD development that has earlier been connected with
a strong cultural basis for obesity, tobacco use and fatty
diet [13-15].
Genotype and allele frequencies (N & %) for all four
examined CVD candidate polymorphisms (ACE I/D,
eNOS-VNTR, LEP G2548A and APOE (ε2, ε3, ε4)) in
Croatian Roma are presented in Table 2. Since no
departure from HW expectations existed we assumed
homogeneity of the studied population with respect to
all four studied polymorphisms.
The relations of all CVD phenotypes with four candi-
date polymorphisms were tested by logistic regression
analysis. The independent variables were tested as quan-
titative and qualitative ones and the better variant for
each phenotype was used. The best models of logistic
regression analyses are presented in Table 3.
The most significant relation among the investigated
CVD risk phenotypes and the four candidate poly-
morphisms was found between APOE ε2a n do b e s i t y
indicators (variables: Waist_C and BMI25). The best
logistic model explains 34.4% of Waist_C variance and
shows that ε2a l l e l e( i . e .g e n o t y p e sε2ε3a n dε2ε4)
increases the risk of high Waist_C phenotype by 3.301
times (95% CI 1.254 - 8.688; p = 0.016). Similarly signifi-
cant findings have been obtained for the variable BMI25
where the best model shows that ε2 allele increases the
risk of having BMI >25 by 3.547 times (95% CI 1.471-
8.557; p = 0.005).
Table 1 Prevalence of non-genetic cardiovascular disease risk factors in Roma population of Croatia (N = 230)
Variable Abbreviation Cut-off value (CODE = 2) % (for CODE = 2)
Age (years) AGE50 ≥ 50 50
Hypertension (mmHg) HT SBP ≥ 140 or DBP ≥ 90 or antihypertensive therapy 44
Glucose (mmol/L) FG ≥ 61 2
Triglycerides (mmol/L) Triglyc_C ≥ 1.7 52
Total cholesterol (mmol/L) Cholest_C ≥ 5.0 78
LDL cholesterol (mmol/L) LDL_C ≥ 3.0 82
HDL cholesterol (mmol/L) HDL_C ≤ 1.0 (males); ≤ 1.2 (females) 16
Body mass index (kg/m
2) BMI25 BMI ≥ 25 58
Waist circumference (cm) Waist_C Waist ≥ 80 (females); ≥ 94 (males) 63
Table 2 Genotype and allele frequencies of ACE I/D,
eNOS-VNTR, LEP_G2548A, and APOE polymorphisms in
Croatian Roma
Polymorphism N (%) HWE p
ACE ID
Genotypes II ID DD
47 (20.7) 112
(49.3)
68 (30.0) 0.997
Alleles ID
206
(45.4)
248
(54.6)
eNOS VNTR
Genotypes 44 45 55
5 (2.4) 42 (20.1) 162
(77.5)
0.328
Alleles 45
52 (12.4) 366
(87.6)
LEP G2548A
Genotypes GG AG AA
25 (11.6) 96 (44.7) 94 (43.7) 0.998
Alleles GA
146
(34.0)
284
(66.0)
APOE
Genotypes E2E3 E2E4 E3E3 E3E4 E4E4
30 (14.4) 12 (5.8) 109
(52.4)
52
(25.0)
5
(2.4)
0.189
Alleles E2 E3 E4
42 (10.1) 300
(72.1)
74 (17.8)
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sented itself as a risk for hypertension, elevated trigly-
cerides, total, LDL or HDL cholesterol. However, two
significant findings emerged and they were related to
decreased risk of hyperlipidemia. This protective relation
showed the combination of allele ε3( A P O E )a n dg e n o -
type 55 (eNOS) for the triglyceride level and the same
combination with addition of genotype II (ACE) for
LDL. 141 participants (71.6%) of the study had the for-
mer protective combination and 31 participants (15.8%)
had the later combination.
Numerous studies revealed the influence of APOE
genotypes on lipid and lipoprotein levels. Generally it
was shown that ε2 allele is associated with decreased
and ε4 with increased total cholesterol level [16-18].
The results of the meta-analysis [17] also indicated a
consistent relationship between plasma triglyceride
levels and apoE phenotype in different populations: tri-
glyceride concentrations were significantly higher in
ε2ε2, ε2ε3, ε3ε4 and ε2ε4 than in ε3ε3 subsets which are
consistent with the results of the present study.
Some studies showed that ε2 allele carriers have
decreased apoE receptor binding capacity in liver, and
transport of VLDL and chylomicrons from blood to hepa-
tocytes, than ε3a n dε4 carriers [16,19]. The association
between high saturated fat intake with increased VLDL
cholesterol, decreased HDL cholesterol and smaller LDL
sizes in ApoE ε2 carriers [20] suggests that in ε2 carriers a
high-saturated fat intake may result in increased VLDL
production and delayed clearance. It seems that modula-
tion of dietary cholesterol absorption, dietary cholesterol,
obesity, sex and even hypolipidemic drug treatment may
also be influenced by APOE polymorphism [21].
Therefore, it is possible that gene-nutrition interac-
tions [22,23] are responsible for the observed association
between ε2 allele and obesity. Namely, our preliminary
study has shown relatively high prevalence of overweight
individuals (58%) among the Croatian Roma which was
Table 3 Logistic regression models for waist circumference (Waist_C), body mass index (BMI25), fasting triglyceride
(Triglyc_C) and LDL cholesterol (LDL_C) concentration in blood
Tested variable Predictor variables OR (95% CI) p
Waist circumference (Waist_C): Sex (males are referent) 3.122 (1.475 - 6.607) 0.003
1 = < 80 cm (F), < 94 cm (M); Age (younger than 50 yrs are referent) 0.728 (0.349 - 1.517) 0.397
2=≥ 80 cm (F), ≥ 94 cm (M) E2 allele of APOE gene (persons who do not have the
genotypes: E2E3 or E2E4 are referent)
3.301 (1.254 - 8.688) 0.016
-2 Log Likelihood = 198.021; Cox & Snell R
2 =
0.251; Nagelkerke R
2 = 0.344
Glucose in blood (mmol/L) 1.959 (1.234 - 3.112) 0.004
Triglyceride in blood (mmol/L) 1.359 (1.043 - 1.770) 0.023
LDL cholesterol in blood (mmol/L) 1.583 (1.043 - 2.403) 0.031
HDL_C (>1.0 (M) and >1.2 (F) are referent) 5.505 (1.542 - 19.650) 0.009
Body mass index (BMI25): Sex (males are referent) 1.027 (0.506 - 2.086) 0.940
1 = BMI < 25; Age (years) 0.979 (0.955 - 1.003) 0.080
2 = BMI ≥ 25 E2 allele of APOE gene (persons who do not have the
genotypes: E2E3 or E2E4 are referent)
3.547 (1.471 - 8.557) 0.005
-2 Log Likelihood = 231.095; Cox & Snell R
2 =
0.181; Nagelkerke R
2 = 0.242
Glucose in blood (mmol/L) 1.323 (0.964 - 1.816) 0.083
Triglyceride in blood (mmol/L) 1.309 (1.041 - 1.646) 0.021
LDL cholesterol in blood (mmol/L) 2.031 (1.369 - 3.014) 0.000
HDL_C (>1.0 (M) and >1.2 (F) are referent) 4.041 (1.521 - 10.737) 0.005
Triglyceride concentration (Triglyc_C): Sex (males are referent) 1.345 (0.702 - 2.578) 0.372
1 = triglyceride concentration < 1.7 mmol/L; Age (younger than 50 yrs are referent) 1.678 (0.911 - 3.091) 0.097
2 = triglyceride concentration ≥ 1.7 mmol/L E3_55 (persons who do not have the combination:
-2 Log Likelihood = 241.753; Cox & Snell R
2 =
0.095; Nagelkerke R
2 = 0.127
E3 (APOE) + 55 (eNOS) are referent) 0.396 (0.199 - 0.785) 0.008
BMI (kg/m
2) 1.046 (0.992 - 1.103) 0.094
Index (= LDH/HDL) 1.337 (0.922 - 1.938) 0.125
LDL cholesterol concentration (LDL_C): Sex (males are referent) 2.682 (1.155 - 6.226) 0.022
1 = LDL concentration < 3.0 mmol/L; Age (younger than 50 yrs are referent) 2.428 (1.024 - 5.760) 0.044
2 = LDL concentration ≥ 3.0 mmol/L E3_55_II (persons who do not have the combination:
-2 Log Likelihood = 144.692; Cox & Snell
R
2 = 0.132; Nagelkerke R
2 = 0.220
0.302 (0.112 - 0.815) 0.018
E3 (APOE) + 55 (eNOS) + II (ACE I/D) are referent) BMI (kg/m
2) 1.153 (1.058 - 1.256) 0.001
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Page 3 of 5connected with unhealthy eating habits resulting from
poverty. They included irregular meals, high consump-
tion of animal fat, coffee and alcohol and low consump-
tion of meat and milk products, fresh vegetables and fruit
[13] which is comparable to the other Roma groups in
Central European countries [24,25]. Although the most
prominent CVD risk factor in Croatian Roma population
is related to the extremely high rates of smoking habit
that is present in 72% men and 69% women [14], it
should be stressed out that they are also characterized by
a high prevalence of increased levels of LDL cholesterol
exceeding the recommended levels in as much as 82% of
the Roma sample. We hypothesize that the nutritional
habits provoke a metabolic response [26,27] that could
reveal a relative susceptibility in ε2 carriers.
The study’sw e a k n e s si si t sl i m i t e ds a m p l es i z ea n di t
must therefore be regarded as preliminary to larger
investigations. These will include the analysis of family
data directed towards confirming linkage between
APOE ε2, ε3, ε4 polymorphism and obesity phenotype.
Additionally, the apolipoprotein E gene-nutrition inter-
actions are planned to be examined in more detail.
The main strength of the study is that it was per-
formed without presumptive hypothesis about the effect
of particular genotypes and thus the possible impact of
each genotype was explored alone and in combination
with other genetic and environmental factors. This
approach enabled the effect of E2 allele to emerge.
In conclusion, APOE polymorphism is a major deter-
minant of CVD risk in the Croatian Roma acting on sev-
eral phenotypic risk traits - obesity indicators and lipid
levels (LDL and triglycerides). While the protective role
of ε3a l l e l ea n dt h er i s ko fε2a n dε4i sn o tan o v e lf i n d -
ing, the strength of the relation of ε2 allele with obesity
indicators is a remarkable result of the present study.
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